skip navigation
National Cancer Institute   U.S. National Institutes of
Rapid Response Surveillance Studies
Contact us

The National Cancer Institute (NCI) has used rapid response surveillance studies to address key issues in cancer surveillance, ranging from small pilot and feasibility studies to larger studies. These studies began in 1987 when the Surveillance, Epidemiology and End-Results (SEER) registries conducted its first population-based Patterns of Care Study. The rapid response surveillance studies were expanded in 1992 to include a broader range of topics. New and emerging issues related to cancer prevention and control can be investigated by the SEER registries using this mechanism that allows studies to move from the initial concept through completion in a relatively short interval, usually within two years. Research areas addressed by these studies have included evaluation of cancer surveillance methodologies and cancer treatment outcomes, and monitoring screening practices linked to cancer outcomes. In addition, these studies have supported pilot and feasibility studies dealing with the development of procedures for enhanced monitoring of health behaviors and risk factors, the expansion of the utility of SEER data through linkage with other databases, and the improvement of the technical aspects of cancer registry operations. Studies conducted under the rapid response surveillance mechanism have served as background for larger research initiatives funded by other federal and private mechanisms.

 Evaluating Methodologic Issues
 Evaluating Cancer Treatment and Outcomes
 Monitoring Screening Practices
 Monitoring Health Behaviors and Risk Factors
 Linking Databases
 Improving Technical Aspects of Registry Operations
Privacy Policy Accessibility Contact Us
National Cancer Institute    Department of Health and Human Services     National Institutes of Health